Bevespi ratings & reviews

Glycopyrrolate, Formoterol
Company: AZN
Brand: Bevespi
Drug class: Respiratory System
+3 more
Respiratory System, Agents for Reactive and Obstructive Airway Diseases, Reactive and Obstructive Airway Disease Combinations, Respiratory Long-Acting Beta-2 Agonists in Combination with Respiratory Long-Acting Muscarinic Antagonists
Overall rating
3.8
full star full star full star half star empty star
Ranked #5
Physician ratings
  • Efficacy: effective for its intended use
  • Safety: safe to use in humans
  • Tolerability: low drug side effects
  • Accessibility: insurance/payer coverage, cost, affordability,formulary coverage, availability in your hospital or practice setting
  • Adherence: patient compliance with treatment
Efficacy
4.0/5
Safety
4.0/5
Tolerability
3.9/5
Accessibility
3.5/5
Adherence
3.6/5

Sermo AI Overview

  • Bevespi is generally well-regarded for its efficacy in treating conditions like COPD and emphysema, with physicians rating its effectiveness and safety positively, often between 4.0 to 5.0, though some patients experience variability in response.
  • Adherence to Bevespi can be challenging for some patients, reflected in scores around 3.0, and concerns about cost and insurance coverage may further affect accessibility and adherence.
  • Despite good tolerability ratings of 4.0 or higher from physicians, some users report minor side effects, such as urinary tract infections and cough, indicating a generally safe but not entirely issue-free experience.
  • While Bevespi shows a range of effectiveness among patients with COPD, delivery system concerns and overall treatment effectiveness have been raised, underscoring mixed experiences among healthcare providers.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Bevespi contains the active ingredients glycopyrrolate, an anticholinergic, and formoterol fumarate, a long-acting beta-adrenergic agonist, formulated as an inhalation aerosol. It is available as a pressurized metered-dose inhaler, administering glycopyrrolate and formoterol fumarate via oral inhalation. Key inactive ingredients include 1,2-Distearoyl-snglycero-3-phosphocholine (DSPC) and calcium chloride, which help form porous particles that are cosuspended with the drug crystals. Bevespi is intended to be used as an inhaler for managing respiratory conditions.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is inhaled through the mouth. Take it as directed on the prescription label at the same time every day. Do not use it more often than directed. Keep taking it unless your care team tells you to stop.

This medication comes with INSTRUCTIONS FOR USE. Ask your pharmacist for directions on how to use this medication. Read the information carefully. Talk to your pharmacist or care team if you have questions.

Talk to your care team about the use of this medication in children. It is not approved for use in children.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.

Where should I keep my medication?

Keep out of the reach of children and pets.

Store at room temperature between 20 and 25 degrees C (68 and 77 degrees F). Keep inhaler away from extreme heat, cold or humidity. Get rid of it 3 months after removing it from the foil pouch, when the dose counter reads "0" or after the expiration date, whichever is first.

To get rid of medications that are no longer needed or have expired:

  • Take the medication to a medication take-back program. Check with your pharmacy or law enforcement to find a location.
  • If you cannot return the medication, ask your pharmacist or care team how to get rid of this medication safely.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions or angioedema—skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing
  • Heart rhythm changes—fast or irregular heartbeat, dizziness, feeling faint or lightheaded, chest pain, trouble breathing
  • Increase in blood pressure
  • Muscle pain or cramps
  • Sudden eye pain or change in vision such as blurry vision, seeing halos around lights, vision loss
  • Trouble passing urine
  • Wheezing or trouble breathing that is worse after use

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

  • Constipation
  • Cough
  • Dry mouth
  • Headache
  • Sore throat
  • Tremors or shaking
  • Trouble sleeping

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Diabetes
  • Glaucoma
  • Heart disease
  • High blood pressure
  • Irregular heartbeat or rhythm
  • Kidney disease
  • Liver disease
  • Prostate disease
  • Seizures
  • Thyroid disease
  • An unusual or allergic reaction to glycopyrrolate, formoterol, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breast-feeding

What may interact with this medication?

Do not take this medication with any of the following:

  • Cisapride
  • Dofetilide
  • Dronedarone
  • Other medications that contain long-acting beta-2 agonists (LABAs) like formoterol, indacaterol, olodaterol, salmeterol, vilanterol
  • Pimozide
  • Thioridazine
  • Ziprasidone

This medication may also interact with the following:

  • Antihistamines for allergy, cough, and cold
  • Certain medications for bladder problems like oxybutynin and tolterodine
  • Certain medications for blood pressure, heart disease, irregular heart beat
  • Certain medications for depression, anxiety, or psychotic disturbances
  • MAOIs like Carbex, Eldepryl, Marplan, Nardil, and Parnate
  • Other medications that contain an anticholinergic like aclidinium, ipratropium, glycopyrrolate, tiotropium, umeclidinium
  • Other medications that prolong the QT interval (cause an abnormal heart rhythm)
  • Steroid medications like prednisone or cortisone
  • Stimulant medications for attention disorders, weight loss, or to stay awake
  • Theophylline

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse.

NEVER use this medication for an acute asthma attack. You should use your short-acting rescue inhaler for an acute attack. If your symptoms get worse or if you need your short-acting inhalers more often, call your care team right away.

This medication can worsen breathing or cause wheezing right after you use it. Be sure you have a short-acting inhaler for acute attacks (wheezing) nearby. If this happens, stop using this medication right away and call your care team.

This medication may increase the risk of serious asthma-related problems. Talk to your care team if you have questions.

Do not treat yourself for coughs, colds or allergies without asking your care team for advice. Some nonprescription medications can affect this one.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence